1/156
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Bipolar Subtypes
-Bipolar __
-Bipolar ___
-____
I, II, Cyclothymia
Bipolar I Manic Phase
-characterized by the DSM-5 to be a distinct period of abnormal and persistent expansive or irritable mood lasting __ week or longer
1
Bipolar I Manic Phase
-___ or more of these symptoms also have to be present (inflated self esteem, decreased need for sleep, pressured and increased speech, racing thoughts, agitation, distractibility, risk taking behavior)
3
Bipolar I Manic Phase
-the bipolar disorder impairs the daily ___ of the patient or the patient has the need for ___
functioning, hospitalization
DIGFAST Symptoms of Mania
D = _____
distractibility
DIGFAST Symptoms of Mania
I = _____
insomnia
DIGFAST Symptoms of Mania
G = _____
grandiosity
DIGFAST Symptoms of Mania
F = _____ of ideas/racing thoughts
flight
DIGFAST Symptoms of Mania
A = _____
agitation
DIGFAST Symptoms of Mania
S = _____, pressured
speech
DIGFAST Symptoms of Mania
T = _____ risks excessively
taking
It is difficult to diagnose bipolar disorders because most patients exist in either the ___ or ___ phase of the illness for the majority of the time
depressive, euthymic
Rapid Cycler: ≥___ cycles per year
4
Slow Cycler: <___ cycles per year
4
It is difficult to diagnose bipolar disorders because there is reluctance to seek treatment during the __ phase
manic
It is difficult to diagnose bipolar disorders because there is a high potential for ___ (including Cluster B personality disorders, ADHD, substance induced, schizoaffective disorder, LD/autism, unipolar vs bipolar depression)
misdiagnosis
Neurochemistry of Mania
-increased dopamine in mesolimbic and nigrostriatal pathways
-___ dopamine in TIF and mesocortical pathways
unchanged
Neurochemistry of Mania
-___ outflow of NE pathways
-____ in release of serotonin (leads to agitation, insomnia, euphoria)
increased, increased
Patient Assessment
The ___ of bipolar disorder influences choice of treatment (mania vs depression vs euthymia)
phase
Patient Assessment
-since there is a strong genetic component of bipolar disorder, if patient has family history of disorder, ask what their family's response to ____ was (if family member doing well on med, it is likely they will do well too)
treatment
Patient Assessment
-determine that patient truly has bipolar disorder and not a different ___ (via interview, history, variability in symptom duration, age, symptom severity, etc)
disorder
Drugs which can precipitate manic episodes
1) ___ (may induce a "switch phenomenon")
2) ____ (eg cocaine, amphetamines)
antidepressants, stimulants
Drugs which can precipitate manic episodes
3) ___ or ___
corticosteroids, androgens
Drugs which can precipitate manic episodes
4) ___ medications
5) synthetic ____ (eg JWH-018 and variants)
thyroid, cannabinoids
Therapeutic Targets-stop a car without wrecking it
1) Hit brakes to stop car rapidly (___ pathway)
GABA
Therapeutic Targets-stop a car without wrecking it
2) Disrupting flow of gas, takes more time (interference with ___ channels)
Na+
Therapeutic Targets-stop a car without wrecking it
3) Taking foot off gas, takes the longest (anti-____ ___)
NMDA glutamate
Meds for BPD
1. ___ ____ (lithium, divalproex, carbamazepine, lamotrigine)
2. ____
3. ____ (controversial)
4. ____
mood stabilizers, antipsychotics, antidepressants, benzodiazepines
Meds for BPD
-____ is an adjunctive/common off-label therapy
oxcarbazepine
What are the brand names of Lithium?
Lithium Carbonate, Eskalith
Lithium is the "gold standard" first line treatment for:
-___ mania
-___
-decreased ____/suicidal thoughts
acute, maintenance, suicidality
Lithium
-MOA is to interfere with ___ channels (disrupts flow of gas)
Na+
Lithium
-disadvantage is very ___ therapeutic index and significant ___ ___ profile
narrow, side effect
Lithium Drug Interactions
1. ____ ____ (allow sodium to be reabsorbed, therefore allowing more lithium to be absorbed, causing lithium toxicity)
thiazide diuretics
Lithium Drug Interactions
2. ____ (causes lithium toxicity)
3. ____ (causes lithium toxicity via angiotensin II decrease)
NSAIDs, ACEI
Lithium Drug Interactions
4. ___ intake (increased intake decreases lithium levels)
5. _____ (caffeine, decreases lithium level)
6. ___/____ (theoretical interaction, minor risk of serotonin syndrome)
sodium, methylxanthines, SSRI/SNRI
Lithium Dosage Forms
-lithium carbonate ___ capsules
-lithium carbonate __ tablets
-lithium carbonate ___ capsules
-lithium citrate ___
IR, CR, ER, liquid
Lithium-Test Question
-8meq/5mL of lithium citrate liquid = ____mg lithium carbonate
300
Lithium Acute Phase Dosing
-start patient on ____mg IR BID and adjust by lithium levels
300
Lithium Acute Phase Dosing
-If CrCl < ____ mL/min, dose adjustment needed because lithium is renally excreted
50
Lithium Acute Phase Dosing
-If CrCl < 50 mL/min, consider starting at 300-450mg po ___ (as opposed to usual BID schedule)
QD
Lithium Acute Phase Dosing
-Average dose is 900-1800 mg/day to achieve target drug level of ___-___ mEq/L
0.8-1.2
Lithium Acute Phase Dosing
-steady state is reached in __-__ days
5-7
Lithium Acute Phase Dosing
-even though steady state is reached in 5-7 days, it takes __-__ days for response (so do not adjust dose before this point)
10-14
Lithium Acute Phase Dosing
-since it takes 10-14 days for response to lithium therapy, we can use ___ and/or ____ adjunctively while we are waiting
benzodiazepines, antipsychotics
Lithium Monitor Drug Serum Levels
-we want a trough
-if patient is on BID dosing, draw level before __ dose
-if patient is on QD CR/ER product that is dosed at night, draw level before ____ dose
morning, evening
Lithium Monitor Drug Serum Levels
-we want a trough because "troughs kill"
-if trough is high, that means ___ will be high, and we can delay dose before toxic peak occurs
peak
Lithium Monitor Drug Serum Levels
-monitor serum drug level and creatinine at __ week, __ months, and then every __ months
1, 3, 6
Lithium Monitor Drug Serum Levels
-we monitor serum drug level and creatinine more frequently if patient has ___ sodium changes, changes in ___ intake, changes in ___, or interacting meds prescribed
dietary, caffeine, hydration
Lithium Other Monitoring-Renal Function/Electrolytes
-____
-Cr, CrCl
-__+
-__+
-glucose
BUN, Na, K
-"Lithium loves the ____"
-At the beginning, lithium can cause a brief hyperthyroid phase
-Shortly after, it more commonly leads to hypothyroidism from decreased thyroid hormone release
thyroid
Lithium Other Monitoring-Thyroid Function Test
-free ___
-____
-____
-reverse __
T4, TSH, T3, T3
Lithium Other Monitoring-Parathyroid Hormone
-____
-___
PTH, Ca
Lithium Other Monitoring
-____ (remember there are sodium channels in heart and vasculature)
-____ (category D-risk outweighs benefit)
ECG, pregnancy
Lithium Continuation and Maintenance Treatment
-re-evaluate lithium levels and continue to target optimal __-___mEq/mL
0.8-1.2
Lithium Continuation and Maintenance Treatment
-clinical pearl: target for MDD augmentation is __-__mEq/L
0.4-0.6
Lithium Continuation and Maintenance Treatment
-Lithium exhibits linear kinetics
-A dose change of 300mg translates into a __-__mEq/L change in plasma concentration (if someone has normal renal function)
0.2-0.4
Lithium Continuation and Maintenance Treatment
-need for lower doses in the __ and those with compromised __ function
elderly, renal
Symptoms which respond in first 2 weeks on lithium therapy:
-less pressured ___
-less psychomotor activity
-less ___
-___ patterns begin to normalize
speech, agitation, sleep
Symptoms which respond later on lithium therapy:
-___
-____ processes
-insight and judgement
delusions, though
Goals of Lithium Therapy
1. prevent next ___ episode
2. prevent lithium ____
manic, toxicity
There will be __-___ side effects during the first 14 days of lithium therapy
self-limiting
Lithium Self-limiting Side Effects
-___ discomfort and ___ (most common)
GI, sedation
Lithium Self-limiting Side Effects
-fine hand ___
-diarrhea, polyuria, polydipsia
tremor
Clinical Pearl: Consider ___ daily bedtime dosing with either IR or ER formulation to improve adherence (the patient will then experience side effects such as fine tremor at night and not during the day)
once
If the self-limiting side effects persist after the first 14 days, consider lithium ____
toxicity
Lithium Long Term Side Effects
-____ gain
-abnormalities in ___ panel (hypothyroidism)
-hyperparathyroidism
weight, thyroid
Lithium Toxicity
mild toxicity → serum levels __-__ mEq/L
1.5-2
Lithium Toxicity
mild toxicity → ___ tremor, nausea, vomiting, diarrhea
fine
Lithium Toxicity
moderate toxicity → serum levels __-__ mEq/L
2-2.5
Lithium Toxicity
moderate toxicity → ___ tremor, ataxia, __-wave changes on ECG
coarse, T
Lithium Toxicity
severe toxicity → serum levels >__ mEq/L
2.5
Lithium Toxicity
severe toxicity → ___ (nearly unconscious), seizures, ___ collapse, arrythmias
stupor, CV
Lithium Patient Counseling
-educate patient as to self-limiting vs persistent side effects and __ presentation
toxicity
Lithium Patient Counseling
-maintain ___ status
-maintain consistent __ intake
-maintain diet consistent in ___
fluid, sodium, caffeine
Lithium Patient Counseling
-changes in other medications may require a recheck of lithium levels
-keep appointments for ___ work
-know when to contact physician (cycle into mania or depression, toxicity signs)
blood
Divalproex Sodium
-Divalproex DR and Divalproex ER are NOT ____
interchangeable
Divalproex
-used to treat __ mania and ___ cycling bipolar disorder
-increasing evidence in mania and mixed mania (off label)
acute, rapid
Divalproex
-MOA is to potentiation of post-synaptic ___ receptor (slam on breaks, fastest onset of all mood stabilizers)
GABA
Divalproex
-can cause ___ toxicity
-highly protein-bound to ___ (remember that free drug is therapeutic)
liver, albumin
Divalproex
-only forms approved for BPD are Depakote __ and Depakote ___
-NOT valproic acid (depakene)
DR, ER
Divalproex Dosing
-500mg QD and titrate up to 1000mg/day based on ___, normal ___ function, and serum ___
weight, hepatic, albumin
Divalproex Alternative Dosing
-If a patient presents with acute mania, there may not be time to wait for liver function or albumin labs, so ____-based dosing can be used to start Divalproex treatment right away
weight
Divalproex Alternative Dosing
-weight x 10, then round down
-ONLY can use this alternative dosing for divalproex __
DR
Divalproex DR
-drug is ___/ionized after activation in low pH of stomach
-drug absorbed in small intestine (jejunum)
released
Divalproex ER
-dual layer tablet
-after dissolution, ionization of outer later, inner layer forms a ___ in the small intestine
gel
DR: absorption occurs about __ hours after administration
ER: small immediate release absorption then __-__ extended release
2, 18-24
DR: peak SDL in __ hours
ER: peak SDL in __ hours (so give in morning so sedation peaks at night)
6, 12
DR: 100% absorption
ER: 80% absorption (so must dose __% higher than DR)
20
DR: dosed __-__ times/day
ER: dosed ___ time/day
2-3, 1
Divalproex Therapeutic Effect
-onset of action and steady state achieved in about __ days (fast!)
4
Divalproex Therapeutic Effect
-___mcg/mL of free drug is needed to cross blood brain barrier
50
Divalproex Therapeutic Effect
-50 mcg/mL is needed to cross blood brain barrier, may be lower in presence of ___ serum albumin (because more free drug)
low
Divalproex Target Serum Drug Levels
Acute Phase → ___-___ mcg/mL
100-125
Divalproex Target Serum Drug Levels
Continuation Phase → ___-___ mcg/mL
50-100
low serum albumin = (~___gm/dL or lower)
3.6
If low serum albumin (~3.6gm/dL or lower), request ___ ___ level OR adjust ___ based on conversion table
free VPA, dose
Kinetics of Divalproex
-drug is bound approximately __% to circulating albumin
-creates a circulating reservoir for divalproex
94
Kinetics of Divalproex
-lower albumin = more __ drug = increased risk for ___
free, toxicity
Divalproex Toxicity
-sedation
-____ (confusion, visual hallucinations, rapid onset, caused by increased serum ammonia)
delirium